Inhibrx Biosciences (INBX) Stock Price, Quote, News & History | Benzinga

Inhibrx Biosciences Inc (INBX) Stock Price, Quote, News & History

INBXNASDAQ

Trade with Public

Trade with Public

$90.52

1.051.17%

Last update: Jun 11, 12:15 PM

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$89.50

Close

-

Volume / Avg.

139.89K / 414.58K

Day Range

$88.23 - $92.34

52 Wk Range

13.92 - 155.29

Market Cap

$1.33B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

28.96%

Days to Cover

9.32

Recent Inhibrx Biosciences Inc News

Inhibrx Cancer Treatment Shows High Response Rates In Head And Neck Cancer Study

Inhibrx Biosciences shares rise after Phase 2 INBRX-106 and Keytruda data showed stronger response rates in head and neck cancer.

Vandana Singh

Large Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges

Inhibrx explores spin-off of INBRX-106 amid Big Pharma interest, with potential valuation exceeding $9 billion pending trial outcomes.

Vandana Singh

Why Inhibrx's Recent Strength May Not Be Built to Last

An analysis of Inhibrx's sharp rally after trial results, highlighting a timing mismatch in the cycle and risks investors should watch.

Shivank Goswami

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-131.93M

Investing Cash Flow (TTM)

-7.00K

Financing Cash Flow (TTM)

77.07M

Free Cash Flow (TTM)

-131.94M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-54.86M

Analyst Trends and Forecast

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.33B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1070.38

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-9.36%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$1.43

Company Debt

Total Debt

$174.99M

LT Debt

$174.99M

LT Debt Issuance (TTM)

$74.99M

LT Debt Repayment (TTM)

-

Total Cash

$161.66M

Debt to Equity

-

Issuance of Debt (TTM)

$74.99M

Repayment of Debt (TTM)

-

Key Statistics

Open

$89.50

Close

-

Volume / Avg.

139.89K / 414.58K

Day Range

$88.23 - $92.34

52 Wk Range

13.92 - 155.29

Market Cap

$1.33B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

28.96%

Days to Cover

9.32

About

Sector

Health Care

Industry

Biotechnology

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates inc...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Inhibrx Biosciences (INBX) stock?

A

You can purchase shares of Inhibrx Biosciences (NASDAQ:INBX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Inhibrx Biosciences (INBX) competitors?

A

There are no as such competitors for Inhibrx Biosciences.

Q

What is the forecast, or price target, for Inhibrx Biosciences (INBX) stock?

A

Inhibrx Biosciences has a consensus price target of $150.00.

Q

What is the current price for Inhibrx Biosciences (INBX)?

A

The stock price for Inhibrx Biosciences (NASDAQ: INBX) is $90.52 last updated June 11, 2026 at 12:15 PM EDT.

Q

Does Inhibrx Biosciences (INBX) pay a dividend?

A

There are no upcoming dividends for Inhibrx Biosciences.

Q

When is Inhibrx Biosciences (NASDAQ:INBX) reporting earnings?

A

Inhibrx Biosciences does not have any upcoming earnings scheduled.

Q

Is Inhibrx Biosciences (INBX) going to split?

A

There is no upcoming split for Inhibrx Biosciences.

Q

What sector and industry does Inhibrx Biosciences (INBX) operate in?

A

Inhibrx Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.